###begin article-title 0
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Polymorphisms of Serotonin Receptor 2A and 2C Genes and COMT in Relation to Obesity and Type 2 Diabetes
###end article-title 0
###begin p 1
Analyzed the data: SIIK. Wrote the paper: SIIK. Edited the manuscript and contributed with comments and suggestions: TW ST AA TH OP TIAS. Contributed to the statistical analyses: CH. Initiated and coordinated the study: TIAS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 52 64 52 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A, 5HT2C</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Candidate genes of psychological importance include 5HT2A, 5HT2C, and COMT, implicated in the serotonin, noradrenaline and dopamine pathways, which also may be involved in regulation of energy balance. We investigated the associations of single nucleotide polymorphisms (SNPs) of these genes with obesity and metabolic traits.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 102 103 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 411 416 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 425 430 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 445 449 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 483 487 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 648 653 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 793 797 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 908 913 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 1142 1147 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 1162 1166 1160 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1465 1470 1463 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 1526 1530 1524 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1585 1586 1581 1582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1667 1672 1663 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 1677 1681 1673 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 1735 1736 1729 1730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 33 36 <span type="species:ncbi:9606">men</span>
###xml 73 76 <span type="species:ncbi:9606">men</span>
In a population of 166 200 young men examined at the draft boards, obese men (n = 726, BMI>/=31.0 kg/m2) and a randomly selected group (n = 831) were re-examined at two surveys at mean ages 46 and 49 years (S-46, S-49). Anthropometric, physiological and biochemical measures were available. Logistic regression analyses were used to assess age-adjusted odds ratios. No significant associations were observed of 5HT2A rs6311, 5HT2C rs3813929 and COMT rs4680 with obesity, except that COMT rs4680 GG-genotype was associated with fat-BMI (OR = 1.08, CI = 1.01-1.16). The SNPs were associated with a number of physiological variables; most importantly 5HT2C rs3813929 T-allele was associated with glucose (OR = 4.56, CI = 1.13-18.4) and acute insulin response (OR = 0.65, CI = 0.44-0.94) in S-49. COMT rs4680 GG-genotype was associated with glucose (OR = 1.04, CI = 1.00-1.09). Except for an association between 5HT2A rs6311 and total-cholesterol at both surveys, significant in S-46 (OR = 2.66, CI = 1.11-6.40), no significant associations were observed for the other phenotypes. Significant associations were obtained when combined genotype of 5HT2C rs3813929 and COMT rs4680 were examined in relation to BMI (OR = 1.12, CI = 1.03-1.21), fat-BMI (OR = 1.22, CI = 1.08-1.38), waist (OR = 1.13, CI = 1.04-1.22), and cholesterol (OR = 5.60, CI = 0.99-31.4). Analyses of impaired glucose tolerance (IGT) and type 2 diabetes (T2D) revealed, a 12.3% increased frequency of 5HT2C rs3813929 T-allele and an 11.6% increased frequency of COMT rs4680 GG-genotype in individuals with IGT or T2D (chi2, p = 0.05 and p = 0.06, respectively). Examination of the combined genotypes of 5HT2C and COMT showed a 34.0% increased frequency of IGT or T2D (chi2, p = 0.01).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The findings lend further support to the involvement of serotonin, noradrenaline and dopamine pathways on obesity and glucose homeostasis, in particular when combined genotype associations are explored.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Clement1">[1]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Kahn1">[2]</xref>
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Martyn1">[3]</xref>
###xml 417 420 417 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Despres1">[4]</xref>
The fundamental causes of obesity relate to a complex interplay between environmental exposure, health behaviour and inherited components [1]. Obesity and body fat distribution are important determinant of glucose homeostasis [2], [3] with insulin resistance as the main contributor to the deleterious consequences of obesity, such as development of metabolic diseases, IGT, T2D and eventually cardiovascular disease [4]. Deeper insights into the genetic control of energy metabolism are warranted in order to improve long-term compliance to prevention programs or therapeutic interventions.
###end p 9
###begin p 10
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Yuan1">[5]</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Schwartz1">[7]</xref>
###xml 415 418 415 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Halford1">[8]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Astrup1">[12]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Zimmermann1">[13]</xref>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Padwal1">[14]</xref>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Malhotra1">[11]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Zimmermann1">[13]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 1086 1090 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Malhotra1">[11]</xref>
Recently, genes with known psychophysiological functions have gained much attention in the field of obesity and a common pathophysiology have been suggested between depression, obesity and related metabolic disorders [5]-[7]. The neurotransmitters, serotonin, noradrenaline and dopamine are important in the central nervous system regulation of many physiological processes including energy and glucose homeostasis [8]-[10]. Consequently, these neural pathways are interesting targets for anti-obesity drugs, antidepressants and agents for treatment of various eating disorders [10]-[12]. However, major drug-induced adverse events include body weight gain in treatment of psychiatric disorders [10], [13] and mood disorders in anti-obesity agents [14]. The large intra- and inter-individual variability in clinical response to antipsychotic drugs and their side effects is further linked to genetic susceptibility [10], [11], [13]. Pharmacogenetic research focuses therefore on identification of specific genes that influence drug response by utilizing a candidate-gene approach [10], [11], although supporting evidence for a role of these genes in development of obesity and associated metabolic traits from population-based observational studies is sparse.
###end p 10
###begin p 11
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(5HT2A)</italic>
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(5HT2C)</italic>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Reynolds1">[15]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Huang1">[16]</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Reynolds2">[17]</xref>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Meyer1">[18]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Pinborg1">[20]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Rosmond2">[21]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Rosmond3">[22]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Parkinson1">[23]</xref>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
A plethora of studies indicates that serotonin (5-hydroxytryptamine; 5HT) receptor 2A (5HT2A) and 2C (5HT2C) are involved in the regulation of appetite and energy homeostasis [15], although with functional differences between the genes [16]. Thus, 5HT2C -759C/T is shown to affect treatment-induced weight gain in schizophrenic patients [17], and 5HT2A -1438G/A has been linked to several neuro-psychiatric disorders [18]-[20] and to abdominal obesity [21], [22]. Transcripts of the serotonin receptor have been found in the hypothalamus, including in the para-ventricular nucleus, lesions of which result in obesity [23].
###end p 11
###begin p 12
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(COMT)</italic>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Halford2">[24]</xref>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang1">[25]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Arranz1">[10]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Malhotra1">[11]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Halford2">[24]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang1">[25]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Malhotra1">[11]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Mannisto1">[26]</xref>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Mannisto1">[26]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang2">[27]</xref>
Catechol-O-methyltransferase (COMT) encodes for the COMT enzyme responsible for the degradation of the catecholamines, dopamine adrenaline and noradrenaline through both central and peripheral effects [24], [25]. There is evidence that changes in the activity of COMT affect sympathetic tone, regulate the amounts of active dopamine and noradrenaline in various cerebral regions and thus is involved in multiple reward-motivated behaviour such as obesity [10], [11], [24], [25], mood and other mental processes [11], [26]. Several polymorphisms of COMT have been described, but 24938A/G (rs4680) is the most extensively studied [26] showing associations with schizophrenia, alcoholism and obesity [27].
###end p 12
###begin p 13
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 204 207 <span type="species:ncbi:9606">men</span>
In the present study, we examined 5HT2A -1438G/A (rs6311), 5HT2C -759C/T (rs3813929) and COMT 24938 A/G (rs4680) in relation to obesity and related metabolic quantitative traits in a group of middle-aged men representing a very broad range of BMI.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study population
###end title 15
###begin p 16
###xml 386 387 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 758 762 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Black1">[28]</xref>
###xml 763 767 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-SonneHolm1">[30]</xref>
###xml 840 847 838 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t001">Table 1</xref>
###xml 24 27 <span type="species:ncbi:9606">men</span>
###xml 186 189 <span type="species:ncbi:9606">men</span>
###xml 216 219 <span type="species:ncbi:9606">men</span>
###xml 787 799 <span type="species:ncbi:9606">participants</span>
###xml 1083 1095 <span type="species:ncbi:9606">participants</span>
###xml 1196 1199 <span type="species:ncbi:9606">men</span>
Among 362 200 Caucasian men examined at the mean age of 20 years at the draft boards in Copenhagen and its surroundings during 1943-77, a randomly selected group of one in every hundred men (n = 3 601) and all obese men (n = 1 930) were manually identified. Obesity was defined as 35% overweight relative to a local standard in use at the time, and this corresponds to a BMI>/=31.0 kg/m2, which proved to be above the 99th percentile. All obese and half of the random sample, still living in the region, were invited to a follow-up survey in 1992-94 at the mean age of 46 years (survey S-46) and in 1998-2000 at the mean age of 49 years (survey S-49). The criteria for invitation to the follow-up surveys and the participation have been described previously [28]-[30], and the number of participants shows the expected attrition over time (Table 1). Phenotypic assessments were carried out at both surveys, though much more thoroughly at the second survey (S-49), and DNA was extracted from blood sample buffy coats at the S-46. In total, 1 557 (726 obese and 831 randomly selected) participants were genotyped for the present study, indicating that the randomly selected group represent 166 200 men originally identified at the draft board examination. Among these 485 (209 obese and 276 randomly selected) had been assessed in S-49.
###end p 16
###begin title 17
###xml 109 121 <span type="species:ncbi:9606">participants</span>
Genotype distribution (%) and minor allele frequencies for the examined genes and SNPs in obese and controls participants.
###end title 17
###begin p 18
The minor alleles are shown in bold-faced letters. SNPs = single nucleotide polymorphisms, Wt = wild type, He = heterozygote, Ho = homozygote, MAF = minor allele frequency.
###end p 18
###begin p 19
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 303 315 <span type="species:ncbi:9606">participants</span>
We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. The Danish Data Protection Agency and the regional Ethical Committee approved the study to be in accordance with the Helsinki Declaration II. All participants signed a written consent before participating.
###end p 19
###begin title 20
Phenotypic measurement
###end title 20
###begin p 21
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-World1">[31]</xref>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Waist circumference (cm) was measured according to the WHO recommendations [31] to the nearest 0.5 cm with the subjects standing, using a nonexpendable linen tape measure,. Total body fat mass (kg) was assessed by bioimpedance at S-46 and from the DEXA scan at S-49. Fat body mass index (fat-BMI; kg/m2) was calculated as total body fat mass (kg) divided by height (m) squared.
###end p 21
###begin p 22
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Black1">[28]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-World2">[32]</xref>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sub>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Hansen1">[33]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Black1">[28]</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Schnohr1">[34]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Buemann1">[35]</xref>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants in S-46 had non-fasting glucose and lipid levels determined on fresh plasma samples. In the S-49 cohort, an oral glucose tolerance test (OGTT) was conducted, except in individuals with diagnosed and therefore likely treated diabetes (n = 10) [28]. Classification of IGT or T2D was done according to the WHO diagnostic criteria [32]. Insulin sensitivity and acute insulin response were assessed by the recently recommended BIGTT indices (BIGTT-SI and BIGTT-AIR, respectively) on the basis of measurements of plasma glucose and serum insulin at the time points 0, 30 and 120 minutes during the OGTT [33]. Details on data collections and measurement of anthropometric and other phenotypic estimates have been described elsewhere [28], [34], [35].
###end p 22
###begin title 23
Molecular genetic analyses
###end title 23
###begin p 24
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Genotyping of 5HT2A -1438G/A (rs6311), 5HT2C -759C/T (rs3813929), and COMT 24938A/G (rs4680) was performed using Taqman allelic discrimination (KBioscience, Herts, UK). Genotype data were obtained in 96.7-98.7% of the DNA samples with a genotype error rate of 0.0%.
###end p 24
###begin title 25
Statistics
###end title 25
###begin p 26
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 448 451 <span type="species:ncbi:9606">men</span>
A likelihood ratio test for an additive, a dominant and a recessive effect of the genotyped SNPs determined that a dominant genetic model was chosen for 5HT2A rs6311 and (wild type versus heterozygous and homozygous genotype), and a recessive genetic model was chosen for the present analyses of COMT rs4680 (wild type and heterozygous genotype versus homozygous genotype). The 5HT2C receptor gene is located at the X chromosome, and therefore the men in the present study had either one C- or T-allele.
###end p 26
###begin p 27
###xml 1616 1620 1616 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Prentice1">[36]</xref>
###xml 1621 1625 1621 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Tan2">[41]</xref>
In order to properly take into account and optimally utilise the strength of the sampling design, the two groups of obese and controls have been analysed together at each follow-up survey S-46 and S-49. The massive enrichment of the right tail of the BMI distribution implies that the data cannot be analysed with BMI or BMI-associated outcomes as response variables in common regression models. Using a dichotomized case-control approach would waste considerable statistical efficiency otherwise gained by using the quantitative phenotypes. Limiting the analyses to obese and control groups would also be a waste of the efficiency that is implicit in the sampling design and would disregard the point in having a sampling from a study population of 166,200 subjects at S-46 and 55,200 subjects at S-49. The greater statistical power of the wide coverage of the quantitative phenotypes was gained by reversing the statistical models for the associations, i.e. estimation of the odds of carrying the particular risk-allele genotype for a given level of the phenotypes. This can be done without distributional assumptions about the phenotypes. Standard logistic regression analysis was applied to assess the odds ratios (ORs) of the genotype (response variable) in relation to the phenotypes (covariates, harmonised as z-scores for obesity phenotypes) in the combined case and control groups. The regression model includes relevant phenotypic predictors of this response. Logistic regressions have previously been applied to genetic association studies in which alleles or genotypes are treated as dependent variables [36]-[41]. All analyses were adjusted for age as a continuous variable. P-values<0.05 were considered statistically significant. Implications of multiple testing are addressed in the discussion. Analyses were performed using SAS statistical procedures (version 9.1; SAS Institute Inc, Cary, NC).
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 164 171 164 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 164 171 164 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t001"><bold>Table 1</bold></xref>
###xml 171 172 171 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
The distribution of the genotypes was almost the same at S-46 and S-49 indicating that the attrition of the study groups by time was not dependent on the genotype (Table 1). Hardy-Weinberg equilibrium for each SNP was tested in controls and revealed no significant departures.
###end p 29
###begin title 30
BMI, fat-BMI and waist circumference
###end title 30
###begin p 31
We estimated the ORs of the genotype (response variable) in relation to the phenotypes (covariates). Results from logistic regression analyses for obesity phenotypes are given in odds ratios with 95% confidence intervals (CIs).
###end p 31
###begin p 32
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 85 98 85 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C &#8211;759C/T</italic>
###xml 169 170 169 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 170 177 170 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t002"><bold>Table 2</bold></xref>
###xml 177 178 177 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Results from the logistic regression analyses showed that neither 5HT2A -1438G/A nor 5HT2C -759C/T was significantly associated with BMI, fat-BMI or waist circumference (Table 2). The COMT 24938A/G was associated with fat-BMI at S-46, where a two-unit increase in fat-BMI increased the odds for the GG-genotype by 8% (OR = 1.08, CI = 1.01-1.16, p = 0.03). COMT 24938A/G was associated with waist circumference at S-46 with borderline significance, where an increment of five cm in waist circumference increased the odds for the GG-genotype by 4% (OR = 1.04, CI = 1.00-1.09, p = 0.06).
###end p 32
###begin title 33
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 224 226 224 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
Odds ratio (OR) including 95% confidence intervals (CI) for 5HT2A rs6311 (dominant effect of the A allele, AA & AG vs GG), 5HT2C rs3813929 (effect of the T vs C alleles) and COMT rs4680 (recessive effect of the G allele, GG vs GA & AA) in relation to obesity phenotypes.
###end title 33
###begin p 34
BMI = body mass index, fat-BMI = fat body mass index.
###end p 34
###begin p 35
Per two-unit increment of BMI or fat-BMI.
###end p 35
###begin p 36
Per five cm increment of waist circumference.
###end p 36
###begin title 37
Metabolic traits
###end title 37
###begin p 38
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 395 396 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 396 403 396 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t003"><bold>Table 3</bold></xref>
###xml 403 404 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 957 964 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t003">Table 3</xref>
There were several statistically significant associations between the examined SNPs and some of the metabolic traits. 5HT2A -1438G/A was associated with serum cholesterol at S-46, where a one-unit (10 mmol/L) increase in cholesterol increased the odds for the minor A-allele 2.7 fold (OR = 2.66, CI = 1.11-6.40, p = 0.03), and an almost similar estimate was seen at S-49, albeit not significant (Table 3). 5HT2C -759C/T was associated with non-fasting plasma glucose at S-49, for which a one-unit (10 mmol/L) increase in glucose increased the odds for the TT-genotype 4.6 fold (OR = 4.56, CI = 1.13-18.4, p = 0.03). Likewise, a one-unit increase in acute insulin response decreased the odds for the TT-genotype by 35% (OR = 0.65, CI = 0.44-0.94, p = 0.02). COMT 24938A/G was associated with plasma glucose levels at S-46 where an increment of a one-unit (10 mmol/L) glucose increased the odds for the GG-genotype by 4% (OR = 1.04, CI = 1.00-1.09, p = 0.05; Table 3). The significant associations for plasma glucose and acute insulin response seemed to persist when adjusted for fat-BMI (data not shown). No significant associations were observed with the other examined metabolic traits.
###end p 38
###begin title 39
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 115 117 115 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 224 226 224 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
Odds ratio (OR) including 95% confidence intervals (CI) for 5HT2A rs6311 (dominant effect of the A allele, AA & AG vs GG), 5HT2C rs3813929 (effect of the T vs C alleles) and COMT rs4680 (recessive effect of the G allele, GG vs GA & AA) in relation to metabolic quantitative traits.
###end title 39
###begin p 40
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</sub>
BP = blood pressure, BIGTT-SI = OGTT-derived index of insulin sensitivity, BIGTT-AIR = OGTT-derived index of acute insulin response, FFA = free fatty acids.
###end p 40
###begin p 41
All values for the S-49 are derived from the OGTT examination and are therefore fasting compared with non-fasting for S-46.
###end p 41
###begin title 42
IGT and T2D
###end title 42
###begin p 43
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 698 699 698 699 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 699 706 699 706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 699 706 699 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t004"><bold>Table 4</bold></xref>
###xml 706 707 706 707 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
Based on the above findings on glucose homeostasis, we examined 5HT2C -759C/T and COMT 24938A/G in relation to IGT and T2D. The 5HT2A -1438G/A did not associate with glucose homeostasis, and therefore associations with IGT or T2D were not examined. Results from logistic regression analyses in 162 subjects with IGT or T2D and 308 glucose-tolerant subjects showed corresponding notable estimates, although of borderline significance. Subjects with IGT or T2D had a trend to increase the odds for the T-genotype for 5HT2C and GG-genotype for COMT 24938A/G by 53% (OR = 1.53, CI = 0.90-2.61, p = 0.12) and 48% (OR = 1.48, CI = 0.91-2.41, p = 0.12), respectively compared to glucose-tolerant subjects (Table 4). Adjustment for fat-BMI did not influence the estimates notably.
###end p 43
###begin title 44
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 161 163 161 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Odds ratio (OR) including 95% confidence intervals (CI) for 5HT2C rs3813929 (effect of the T vs C alleles) and COMT rs4680 (recessive effect of the G allele, GG vs GA & AA) in relation to IGT and T2D compared to glucose-tolerant subjects before and after adjustment for fat-BMI (kg/m2).
###end title 44
###begin p 45
IGT = impaired glucose tolerance, T2D = type 2 diabetes, fat-BMI = fat body mass index.
###end p 45
###begin p 46
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 152 153 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 289 290 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 290 299 288 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 290 299 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006696-g001"><bold>Figure 1A</bold></xref>
###xml 299 300 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 302 306 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 491 492 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 590 591 586 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 591 600 587 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 591 600 587 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006696-g001"><bold>Figure 1B</bold></xref>
###xml 600 601 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
In total, 46.5% of the subjects with the T-genotype of 5HT2C -759C/T had IGT or T2D, whereas only 34.2% subjects with the C-genotype had IGT or T2D (chi2: p = 0.05), implying a 12.3% increased frequency of the T-allele in the presence of IGT or T2D compared with glucose tolerant subjects (Figure 1A). COMT 24838A/G was also associated with IGT and T2D. In total, 41.9% of the subjects with the GG-genotype had IGT or T2D, whereas only 30.3% subjects with the AA genotype had IGT or T2D (chi2: p = 0.06), implying 11.6% increased frequency of the GG-genotype, in the presence of IGT or T2D (Figure 1B).
###end p 46
###begin title 47
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 150 153 <span type="species:ncbi:9606">men</span>
Frequency of IGT or T2D according to 5HT2C -759C/T, COMT 24938A/G and combined genotype analysis in the combined group of obese and randomly selected men.
###end title 47
###begin p 48
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 88 90 88 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 143 145 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 252 254 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 270 271 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 280 282 278 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 298 299 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 308 310 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 326 327 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Values are given as percentages. A: Frequency of IGT or T2D according to 5HT2C -759C/T. B: Frequency of IGT or T2D according to COMT 24938A/G. C: Frequency of IGT or T2D according to combination of 5HT2C -759C/T T-allele and COMT 24938A/G GG-genotype. A: P-value for chi2 = 0.05, B: P-value for chi2 = 0.06, C: P-value for chi2 = 0.01.
###end p 48
###begin title 49
Combined effect of 5HT2C and COMT
###end title 49
###begin p 50
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
Based on the present findings on glucose homeostasis, IGT and T2D for 5HT2C and COMT, we examined the combined genotype association of the minor risk genotypes of 5HT2C and COMT in relation to obesity and related metabolic traits. In total, 58 (4.7%) subjects were carriers of both 5HT2C -759T and GG-genotype of COMT 24938A/G. Analysis of the combined genotype has been conducted only in S-46, because of a low number of carriers in S-49 (n = 12).
###end p 50
###begin p 51
###xml 288 289 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 289 296 289 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006696-t005"><bold>Table 5</bold></xref>
###xml 296 298 296 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
We observed significant associations between carriers of the combined risk genotype, all obesity phenotypes and total serum cholesterol. A two-unit increase in BMI was associated with increased odds for being carrier of the combined genotype by 12% (OR = 1.12, CI = 1.03-1.21, p = 0.006) (Table 5). Likewise a two-unit increase in fat-BMI increased the odds for being carrier of the combined genotype by 22% (OR = 1.22, CI = 1.08-1.38, p = 0.002). Each increment of five cm in waist circumference increased the odds for being carrier of the combined genotype by 13% (OR = 1.13, CI = 1.04-1.22, p = 0.003). Lastly, a one-unit (10 mmol/L) increase in total serum cholesterol increased the odds for being carrier of the combined genotype 5.6 fold (OR = 5.60, CI = 0.99-31.4, p = 0.05). Adjustment for fat-BMI showed that the associations between the combined risk genotype, BMI, waist circumference and total serum cholesterol were in part explained by an effect of fat-BMI.
###end p 51
###begin title 52
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt111">2</xref>
Combined genotype analyses. Odds ratio (OR) including 95% confidence intervals (CI) for 5HT2C T-allele (rs3813929) and COMT GG-genotype (rs4680) in relation to metabolic quantitative traits before and after adjustment for fat-BMI (kg/m2).
###end title 52
###begin p 53
BMI = body mass index, fat-BMI = fat body mass index, BP = blood pressure.
###end p 53
###begin p 54
p- = plasma, s- = serum.
###end p 54
###begin p 55
Per two-unit increment of BMI or fat-BMI.
###end p 55
###begin p 56
Per five cm increment of waist circumference.
###end p 56
###begin p 57
###xml 165 166 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 178 179 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 179 188 177 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 179 188 177 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006696-g001"><bold>Figure 1C</bold></xref>
###xml 188 189 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
Carriers of the combined risk genotype were also associated with IGT or T2D, where 66.7% of the carriers had IGT or T2D compared with only 32.6% in non-carriers (chi2: p = 0.01) (Figure 1C).
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2A</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
The present study revealed that the examined SNPs of 5HT2A and 5HT2C did not associate with obesity, but COMT 24938A/G was associated with fat-BMI. Associations were observed between the examined SNPs, glucose homeostasis, serum cholesterol level and a surrogate measure of acute insulin response. Combined genotype analysis of 5HT2C -759C/T and COMT 24938A/G revealed associations in relation to BMI, fat-BMI, waist circumference and serum cholesterol levels, and were partly explained by a possible mediating effects of fat-BMI. 5HT2C -759T and the GG-genotype for COMT 24938A/G showed an increased frequency in subjects with IGT or T2D. The combined genotype analyses accentuated these effects and showed that carriers of the combined risk genotype had increased frequency of IGT or T2D. The present results have not been replicated and, given the experience of complex trait genetics, warrant caution in interpretation.
###end p 59
###begin p 60
###xml 62 65 <span type="species:ncbi:9606">men</span>
###xml 792 804 <span type="species:ncbi:9606">participants</span>
###xml 1524 1536 <span type="species:ncbi:9606">participants</span>
The present population-based cohort study of Danish Caucasian men where the controls were randomly selected from the same population in which the cases were identified effectively prevents population stratification. The availability of several repetitive measurements in the same individuals have given the unique opportunity of analyzing and comparing a panel of specific obesity-related phenotypes covering BMI, fat-BMI, waist circumference and metabolic traits at two different ages. The samples may seem small for a genetic association study; however, this apparent limitation of the study is counteracted by the fact that the control group represents approximately 200 times the size of the randomly selected control group originally identified at the draft board examination. The obese participants therefore were representing the most extreme range of the obesity-related phenotypes in this population at both surveys except for the possible effects of differential attrition of the population during the follow-up. The statistical efficiency of the current sampling design, when analyzed as dichotomized case-control studies, corresponds to about half what would be achieved by investigating the full cohort. Keeping the phenotypes as quantitative variables in the analyses, the efficiency is considerably higher as reflected in the fairly narrow CIs, which means that we thereby have narrowed down the likely true OR's that could have given rise to the observed ORs. Thus, owing to the sampling design of the obese participants with massive enrichment of the right tail of the BMI distribution it is possible to demonstrate stronger associations in our cohort compared to already published studies examining obesity-related genotype-phenotype associations.
###end p 60
###begin p 61
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Benjamini1">[42]</xref>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Benyamin1">[43]</xref>
By nature, our findings are exploratory, and the significant P-values were therefore not corrected for multiple hypotheses testing. Estimating the false discovery rate by the method of Benjamini and Hochberg [42], the adjusted P-value for 68 dependent tests would be 0.011, which implies that all significant associations, except for the combined genotype analyses in relation to obesity, would be false-positive. None of the exploratory results would reach the enhanced significance criterion under application of the conservative Bonferroni correction for an overall type I error rate of 0.05 (one false-positive per 20 tests), which would result in a significance threshold of 0.0007. The examined phenotypes may be inter-correlated to various extents, but according to a recent twin study [43], there is little common underlying genetic or shared environmental aetiology behind these correlations, which justifies the separate analysis of each of the phenotypes in the present study.
###end p 61
###begin p 62
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Yuan1">[5]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Pooley1">[44]</xref>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Iordanidou1">[45]</xref>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 943 948 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 214 219 <span type="species:ncbi:9606">women</span>
###xml 467 472 <span type="species:ncbi:9606">women</span>
###xml 539 544 <span type="species:ncbi:9606">women</span>
###xml 561 566 <span type="species:ncbi:9606">women</span>
###xml 816 819 <span type="species:ncbi:9606">men</span>
###xml 824 829 <span type="species:ncbi:9606">women</span>
###xml 1143 1146 <span type="species:ncbi:9606">men</span>
Although, we have avoided sex-related confounding, which otherwise may have an impact on the genetic variation of body composition, the results suggest that also the role of the gene variants should be examined in women. The -759T allele is functional and has been associated with increased promoter activity compared with the wild type -759C allele [5]. There is indication of sex-related effects and one study has reported higher frequency of the C-allele in obese women, which was associated with weight loss resistance in heterozygote women suggesting that women are more prone to serotonin-induced weight changes [44]. Only one recently published study has examined the effect of -759C/T of the 5HT2C receptor gene on obesity and T2D in a population-based study design [45]. Results from the study of 315 Greek men and women showed a positive association between 5HT2C rs3813929 and T2D, but not with BMI. However, in the same study, the 5HT2C -759T allele frequency was 10.7% lower in diabetic individuals compared to glucose tolerant individuals, which is in discordance with our finding of a 12% increased frequency of the T-allele in men with IGT or T2D (accentuated by combined genotype analysis). The present discrepancy may be ascribed to a high mean age of the Greek subjects and a small study population not enriched on obesity.
###end p 62
###begin p 63
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang2">[27]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Need1">[46]</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Tunbridge1">[47]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Mannisto1">[26]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Need1">[46]</xref>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Halford2">[24]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang2">[27]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Annerbrink1">[48]</xref>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Annerbrink1">[48]</xref>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 897 901 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 936 940 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang2">[27]</xref>
###xml 1315 1319 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Astrup1">[12]</xref>
###xml 1321 1325 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Wang1">[25]</xref>
###xml 1308 1314 <span type="species:ncbi:9606">humans</span>
COMT has been studied intensively in relation to several reward-motivated behaviours such as development of diet-induced obesity [27], [46]. It is known that the G-allele of COMT rs4680 is associated with low COMT activity of soluble COMT, thus conferring slow detoxification of neurotransmitters [47] such as the degradation and inactivation of dopamine [26], [46]. We found an association between COMT 24938A/G and fat-BMI, and borderline with waist circumference, which is in accordance with the suggested role of COMT polymorphisms in obesity [24], [27], [48] and in line with results from a recently published population-based study showing an association between COMT 24938A/G and body fat distribution measured as waist-hip ratio [48]. In a recent randomized controlled trial, no association between COMT 24938A/G and obesity was observed, yet a significant association between a different COMT SNP (rs4818) and BMI was reported [27]. However, because COMT is affecting both the degradation of noradrenaline and dopamine, a decreased activity of the gene product will enhance the post-receptor effects of these neurotransmitters. In this context, it is interesting that re-uptake inhibition on these two systems, that will tend to have the same effect, is an effective way to produce a weight loss in humans [12], [25].
###end p 63
###begin p 64
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Halford1">[8]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Despres2">[49]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006696-Schwartz2">[50]</xref>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5HT2C</italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COMT</italic>
While, there is increasing appreciation for the role of serotonin, noradrenaline and dopamine pathways in energy homeostasis and hence as targets for development of effective anti-obesity agents [8], [49], [50], we did not detect associations of significant importance with obesity. At first step, our results suggested that 5HT2C -759C/T and COMT 29438A/G is associated with IGT and T2D, but partly independent of obesity. However, our results also implied that the combined genotypes of 5HT2C -759C/T and COMT 29438A/G may have an impact on obesity and thus, in this way, on the development of IGT or T2D. The present and potential discrepancies between studies underline the continuing challenges of studies with different populations with different characteristics and pathophysiological and life-style related characteristics that may modify the effects of the examined gene variants.
###end p 64
###begin p 65
Our findings lend further support to the involvement of serotonin, noradrenaline and dopamine in energy and glucose homeostasis, and hence on the risk of obesity and T2D, in particular when combined genotype associations are explored. The results underscore the need for additional research in order to replicate the results and to identify the complex interplay between the examined psychophysiological genes that may further characterize their functionality in energy homeostasis.
###end p 65
###begin p 66
This work is part of the project HEPADIP (Hepatic and adipose tissue and functions in the metabolic syndrome; ).
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
Obesity: Genomics and Postgenomics. Informa Healthcare.
###end article-title 68
###begin article-title 69
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
###end article-title 69
###begin article-title 70
Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms.
###end article-title 70
###begin article-title 71
Health consequences of visceral obesity.
###end article-title 71
###begin article-title 72
Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes.
###end article-title 72
###begin article-title 73
Obesity and depression: same disease, different names?
###end article-title 73
###begin article-title 74
Diabetes, Obesity, and the Brain.
###end article-title 74
###begin article-title 75
Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.
###end article-title 75
###begin article-title 76
Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.
###end article-title 76
###begin article-title 77
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
###end article-title 77
###begin article-title 78
Genomics and the future of pharmacotherapy in psychiatry.
###end article-title 78
###begin article-title 79
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease.
###end article-title 79
###begin article-title 80
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.
###end article-title 80
###begin article-title 81
Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
###end article-title 81
###begin article-title 82
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
###end article-title 82
###begin article-title 83
###xml 63 67 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Differential expression of 5-HT2A and 5-HT2C receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity.
###end article-title 83
###begin article-title 84
Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.
###end article-title 84
###begin article-title 85
Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm.
###end article-title 85
###begin article-title 86
###xml 91 99 <span type="species:ncbi:9606">patients</span>
5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
###end article-title 86
###begin article-title 87
###xml 43 48 <span type="species:ncbi:9606">human</span>
The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined.
###end article-title 87
###begin article-title 88
5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol.
###end article-title 88
###begin article-title 89
Increased Abdominal Obesity in Subjects with a Mutation in the 5-HT2A Receptor Gene Promoter.
###end article-title 89
###begin article-title 90
Dissociative analysis of ventromedial hypothalamic obesity syndrome.
###end article-title 90
###begin article-title 91
###xml 20 25 <span type="species:ncbi:9606">human</span>
The pharmacology of human appetite expression.
###end article-title 91
###begin article-title 92
Brain dopamine and obesity.
###end article-title 92
###begin article-title 93
Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.
###end article-title 93
###begin article-title 94
Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
###end article-title 94
###begin article-title 95
Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes.
###end article-title 95
###begin article-title 96
Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype.
###end article-title 96
###begin article-title 97
###xml 124 127 <span type="species:ncbi:9606">men</span>
Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men.
###end article-title 97
###begin article-title 98
Physical status: The Use and Interpretation of Anthropometry Report of a WHO Expert Committee.
###end article-title 98
###begin article-title 99
Definition, diagnosis and classification of Diabetes Mellitus and its complications.
###end article-title 99
###begin article-title 100
The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.
###end article-title 100
###begin article-title 101
The Copenhagen City Heart Study.
###end article-title 101
###begin article-title 102
Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin.
###end article-title 102
###begin article-title 103
Use of the logistic model in retrospective studies.
###end article-title 103
###begin article-title 104
Nontraditional Epidemiologic Approaches in the Analysis of Gene Environment Interaction: Case-Control Studies with No Controls!
###end article-title 104
###begin article-title 105
###xml 34 39 <span type="species:ncbi:9606">human</span>
Haplotype association analysis of human disease traits using genotype data of unrelated individuals.
###end article-title 105
###begin article-title 106
A logistic regression based extension of the TDT for continuous and categorical traits.
###end article-title 106
###begin article-title 107
Statistical methods for the analysis of genetic association studies
###end article-title 107
###begin article-title 108
###xml 89 94 <span type="species:ncbi:9606">human</span>
Retrospective analysis of main and interaction effects in genetic association studies of human complex traits.
###end article-title 108
###begin article-title 109
Controlling the false discovery rate: A practical and powerful approach to multiple testing.
###end article-title 109
###begin article-title 110
Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome?
###end article-title 110
###begin article-title 111
###xml 87 92 <span type="species:ncbi:9606">women</span>
A 5-HT2C receptor promoter polymorphism (HTR2C - 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes.
###end article-title 111
###begin article-title 112
The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians.
###end article-title 112
###begin article-title 113
Obesity is associated with genetic variants that alter dopamine availability.
###end article-title 113
###begin article-title 114
###xml 122 125 <span type="species:ncbi:10116">rat</span>
Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.
###end article-title 114
###begin article-title 115
###xml 112 115 <span type="species:ncbi:9606">men</span>
Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men.
###end article-title 115
###begin article-title 116
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
###end article-title 116
###begin article-title 117
Central nervous system control of food intake.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study is financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

